Answers are grounded in this paper and cite their sources.
Peri-implantitis is a biofilm-associated inflammatory condition characterised by inflammation of the peri-implant mucosa and progressive loss of supporting bone. Implant surface decontamination is central to its treatment, but it remains uncertain whether decontamination permits re-osseointegration or only contributes to disease resolution. This scoping review mapped the evidence on implant surface decontamination methods and characterised the type of evidence available for re-osseointegration. The review followed the Arksey and O’Malley framework and is reported according to PRISMA-ScR. PubMed, Scopus and Web of Science were searched, with supplementary searching of Google Scholar, for records published from January 2000 to September 2025, and reference lists of included sources were screened. Eligibility was defined with the Population–Concept–Context framework. Sources were charted by design, disease entity, treatment setting, decontamination modality and the highest level of evidence reported for re-osseointegration (histological, radiographic, clinical or laboratory). Of 267 records identified (211 after removal of duplicates), 91 full-text reports were assessed and 55 sources were included: 35 primary studies (12 randomised controlled trials, 12 non-randomised clinical studies, one animal study and 10 in vitro studies) and 20 secondary sources (systematic and narrative reviews and one book chapter). Among primary studies, mechanical decontamination ( n = 8), head-to-head comparisons across modality classes ( n = 8) and laser or photodynamic approaches ( n = 6) were investigated most often. Clinical studies mainly reported probing pocket depth, bleeding on probing, suppuration and marginal bone level. Histological evidence of re-osseointegration was limited to one human case report (four implants; 5.7%–39.0% re-osseointegration) and one canine study; no randomised trial reported histological outcomes. Two clinical studies concerned peri-implant mucositis and therefore could not inform re-osseointegration. Clinical and radiographic improvement after several decontamination protocols is well documented, but direct evidence that any method restores bone-to-implant contact in humans is confined to isolated histological reports. How often a protocol has been investigated does not indicate how effective it is. Future studies should report peri-implantitis and peri-implant mucositis, and surgical and non-surgical settings, separately, and should include histological or other direct measures of re-osseointegration where this is ethically and practically feasible.
No takes yet. Share an insight, caveat, or question.
Dandekeri et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: